John M. Capek is President & VP at ABBOTT LABORATORIES (ABT). They have made 7 open-market trades across 1 company since 2012, most recently 2023-02-28.
CIK 0001328034
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2021-12-13 | 2021-12-15 | $135.05 | $20.2M | +3.7% | -5.4% | -13.3% |
| ABT | SELL | 2020-08-27 | 2020-08-31 | $111.86 | $5.9M | -3.9% | -0.1% | -0.7% |
| ABT | SELL | 2020-04-21 | 2020-04-23 | $95.87 | $9.6M | -1.5% | -5.3% | +6.1% |
| ABT | SELL | 2019-06-20 | 2019-06-21 | $85.00 | $4.0M | +1.0% | +3.9% | -1.8% |
| ABT | SELL | 2018-07-25 | 2018-07-26 | $65.00 | $4.2M | -1.2% | +2.0% | +2.2% |
| ABT | SELL | 2017-02-21 | 2017-02-22 | $45.00 | $4.2M | +0.2% | -0.6% | -3.0% |
| ABT | SELL · 10b5-1 | 2015-02-04 | 2015-02-06 | $45.83 | $455K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2015-02-04 | 2015-02-06 | $45.77 | $1.8M | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2015-02-04 | 2015-02-06 | $45.66 | $1.6M | -8.3% | -2.3% | -2.3% |
| ABT | SELL | 2012-03-05 | 2012-03-07 | $57.37 | $5.7M | -8.3% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.